Immunization with a synthetic multiepitope antigen induces humoral and cellular immune responses to hepatitis C virus in mice

Viral Immunology

Volumn 20, Issue 1, 2007, Pages 170-179

  Chen, Lishan ^a   Gao, Tienjun ^b   Yang, Nan ^a   Huang, Jiansheng ^c   Chen, Yuhan ^a   Gao, Tong ^a   Li, Qihan ^d   Ren, Daming ^a  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^d INSTITUTE OF MEDICAL BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FREUND ADJUVANT; HEPATITIS C VACCINE; IMMUNOGLOBULIN G ANTIBODY; MULTIEPITOPE PCX3 ANTIGEN; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BAGG ALBINO MOUSE; CELLULAR IMMUNITY; CHIMERA; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMORAL IMMUNE DEFICIENCY; IMMUNIZATION; IMMUNOGENICITY; MALE; MOUSE; NONHUMAN; SERUM; TANDEM REPEAT; TRANSGENIC MOUSE; VIRUS LOAD; VIRUS PARTICLE;

ANIMALS; EPITOPES; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C ANTIGENS; IMMUNIZATION; MALE; MICE; MICE, INBRED BALB C; PLASMIDS; T-LYMPHOCYTES, CYTOTOXIC; VIRAL HEPATITIS VACCINES; VIRAL PROTEINS;

HEPATITIS C VIRUS; MUS; MUS MUSCULUS;

EID: 34247191554     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2006.0067     Document Type: Article

References (33)

1. An LL, Rodriguez F, Harkins S, Zhang J, and Whitton JL: Quantitative and qualitative analyses of the immune responses induced by a multivalent minigene DNA vaccine. Vaccine 2000;18:2132-2141.
2. Bowen DG, and Walker CM: Adaptive immune response in acute and chronic hepatitis C virus infection. Nature 2005;436:946-952.
3. Chisari FV: Unscrambling hepatitis C virus-host interactions. Nature 2005;436:930-932.
4. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, and Houghton M: Isolation of a cDNA clone derived from a blood-borne non-A non-B viral hepatitis genome. Science 1989;244:359-362.
5. Demotz S, Lanzavecchia A, Eisel U, Niemann H, Widmann C, and Corradin G: Delineation of several DR-restricted tetanus toxin T cell epitopes. J Immunol 1989;142:394-402.
6. Dienstag JL, and McHutchison JG: American Gastroenterological Association technical review on the management of hepatitis C. Gastroenterology 2006;130:231-264.
7. Fairweather NF, and Lyness VA: The complete nucleotide sequence of tetanus toxin. Nucleic Acids Res 1986;14: 7809.
8. Feld JJ, and Hoofnagle JH: Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature 2005;436:967-972.
9. Houghton M, and Abrignani S: Prospects for a vaccine against the hepatitis C virus. Nature 2005;436:961-966.
10. Huang JS, Peng CX, Xie YM, Zhang Q, Shen XR, Ji DM, Said AS, Jia FX, Kazunari KY, Xu Z, Zheng WY, Lan HK, Guo MQ, and Ren DM: Specific immune responses induced by multi-epitope antigen of HCV in mice and rabbit. Chin Sci Bull 2000;45:896-901.
11. Inchauspe G, Zebedee SL, Lee D, Sugitani M, Nasoff M, and Prince AM: Genomic structure of the human prototype strain H of hepatitis C virus: Comparison with American and Japanese isolates. Proc Natl Acad Sci USA 1991;88: 10292-10296.
12. Lanford RE, Notvall L, Barbosa LH, and Eichberg JW: Evaluation of a chimpanzee colony for antibodies to hepatitis C virus. J Med Virol 1991;34:148-153.
13. Langeveld JP, Casal JI, Osterhaus AD, Cortes E, de Swart R, Vela C, Dalsgaard K, Puijk WC, Schaaper WM, and Meloen RH: First peptide vaccine providing protection against viral infection in the target animal: Studies of canine parvovirus in dogs. J Virol 1994;68:4506-4513.
14. Langeveld JP, Kamstrup S, Uttenthal A, Strandbygaard B, Vela C, Dalsgaard K, Beekman NJ, Meloen RH, and Casal JI: Full protection in mink against mink enteritis virus with new generation canine parvovirus vaccines based on synthetic peptide or recombinant protein. Vaccine 1995;13: 1033-1037.
15. + T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur J Immunol 2000;30:2479-2487.
16. Lin HJ, Lau JY, and Lauder IJ: The hepatitis C virus genome: A guide to its conserved sequences and candidate epitopes. Virus Res 1993;30:27-33.
17. Li QH, Dong CH, Wang J, Che YC, Li J, Wang JJ, Sun M, Wang LC, Huang JS, and Ren DM: Induction of hepatitis C virus-specific humoral and celluar immune response in mice and rhesus by synthetic multiple epitopes sequence. Viral Immunol 2003;16:321-333.
18. Mateo L, Gardner J, Chen Q, Schmidt C, Down M, Elliott SL, Pye SJ, Firat H, Lemonnier FA, Cebon J, and Suhrbier A: An HLA-A2 polyepitope vaccine for melanoma immunotherapy. J Immunol 1999;163:4058-4063.
19. Mercer DF, Schiller DE, Elliott JF, Douglas DN, Hao CH, Rinfret A, Addison WR, Fischer KP, Churchill TA, Lakey JR, Tyrrell DL, and Kneteman NM: Hepatitis C virus replication in mice with chimeric human livers. Nat Med 2001; 7:927-933.
20. Mueller HM, Pfaff E, Heller AE, Goeser T, and Theilmann L: Complete sequence of a German isolate of hepatitis C virus (HCV) derived from a serum of a patient after liver transplantation due to HCV induced hepatocellular carcinoma (1996, unpublished). Available at GenBank accession number HCU45476.
21. Sandres-Saune K, Deny P, Pasquier C, Thibaut V, Duverlie G, and Izopet J: Determining hepatitis C genotype by analyzing the sequence of the NS5b region. J Virol Methods 2003;109:187-193.
22. Sarbah S, and Younossi Z: Hepatitis C: An update on the silent epidemic. J Clin Gastroenterol 2000;30:125-143.
23. Shirai M, Arichi T, Nishioka M, Nomura T, Ikeda K, Kawanishi K, Engelhard VH, Feinstone SM, and Berzofsky JA: Cytotoxic T Lymphocyte (CTL) response of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1. J Immunol 1995;154:2733-2742.
24. Shirai M, Okada H, Nishioka M, Akatsuka T, Wychowski C, Houghten R, Pendleton CD, Feinstone SM, and Berzofsky JA: An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J Virol 1994;68:3334-3342.
25. Sienoneit K, Silva MD, and Koerner K: Human monoclonal antibodies for the immunological characterization of a highly conserved protein domain of the hepatitis C virus glycoprotein. Clin Exp Immunol 1995;101:278-285.
26. + cytotoxic T cells:implications for vaccine design. Proc Natl Acad Sci USA 1995;92: 5845-5849.
27. Trowbridge R, and Gowans EJ: Molecular cloning of an Australian isolate of hepatitis C virus. Arch Virol 1998;143: 501-511.
28. Weiner A, Eriskson AL, and Kansopon J: Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc Natl Acad Sci USA 1995;92:2755-2759.
29. Wong JB, McQuillan GM, McHutchison JG, and Poynard T: Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000;90: 1562-1569.
30. + cytotoxic T-cell epitopes. J Virol 1999;73:5320-5325.
31. Yanagi M, Clare SM, Shapiro M, Emerson SU, Purcell RH, and Bukh J: Transcripts of a chimeric clone of hepatitis C virus genotype 1b are infectious in vivo. Virology 1998; 244:161-172.
32. Yang W, Jackson DC, Zeng QR, and McManus DP: Multi-epitope schistosome vaccine candidates tested for protective immunogenicity in mice. Vaccine 2001;19: 103-113.
33. Zhou YH, Shimizu YK, and Esumi M: Monoclonal antibodies to the hypervariable region 1 of hepatitis C virus capture virus and inhibit virus adsorption to susceptible cells in vitro. Virology 2000;269:276-283.